Fortress BiotechFBIO
那斯達克 · USD
2.98
+0.04
(+1.36%)
盤中 12/12 11:06 (UTC+8)
12/12 11:06 (UTC+8)
Fortress BiotechFBIO
2.98
+0.04
(+1.36%)
財務數據
損益表
- 0.17
- 0.35
- 0.20
- 0.13
- 0.15
- 0.15
- 0.15
- 0.13
- 0.16
- 0.18
- 39.88
- 99.88
- -42.60
- -34.67
- 14.32
- -1.79
- 3.36
- -13.10
- 24.92
- 7.42
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 17,631 | 16,413 | 13,139 | 15,120 | 14,629 | 14,896 | 13,030 | 19,946 | 34,752 | 17,386 |
營業成本 | 5,755 | 4,939 | 4,790 | 4,680 | 6,914 | 7,355 | 6,816 | 6,015 | 6,429 | 7,767 |
營業毛利 | 11,876 | 11,474 | 8,349 | 10,440 | 7,715 | 7,541 | 6,214 | 13,931 | 28,323 | 9,619 |
營業費用 | 18,518 | 47,947 | - | 34,275 | 29,907 | - | - | - | 42,079 | 59,724 |
研發費用 | 208 | 8,122 | 3,938 | 9,688 | 9,446 | 12,656 | 24,839 | 14,045 | 20,287 | 32,139 |
推銷及管理費用 | 17,246 | 38,761 | 25,663 | 22,563 | 22,090 | 20,836 | 17,941 | 22,643 | 21,792 | 24,442 |
非經常性項目費用 | - | - | - | 1,043 | - | 2,649 | - | -3,143 | - | 3,143 |
其他營業費用 | 1,064 | 1,064 | 1,065 | 981 | -1,629 | -814 | - | - | - | - |
營業利益 | -6,642 | -36,473 | -22,317 | -23,835 | -22,192 | -27,786 | -36,566 | -19,614 | -13,756 | -50,105 |
其他收入及費用 | 18,406 | 27,338 | 431 | 450 | 1,683 | 1,085 | 145 | -6,931 | 5,708 | -2,771 |
利息費用 | 2,741 | 2,519 | 2,805 | 2,594 | 6,209 | 2,122 | 2,602 | 2,060 | 2,534 | 6,425 |
稅前純益 | 9,023 | -11,654 | -24,691 | -25,979 | -26,718 | -28,823 | -39,023 | -28,605 | -10,582 | -59,301 |
所得稅 | 196 | - | - | 336 | -24 | - | - | 379 | 142 | - |
稅後純益 | 5,850 | 15,486 | -10,584 | -6,765 | -12,867 | -10,948 | -15,417 | -9,279 | -5,045 | -24,776 |
基本每股稅後盈餘(元) | 0.13 | 0.50 | -0.48 | -0.16 | -0.76 | -0.73 | -1.04 | - | -0.06 | -0.24 |
稀釋每股稅後盈餘(元) | 0.12 | 0.50 | -0.48 | -0.26 | -0.67 | -0.72 | -1.04 | -0.53 | -0.05 | -0.24 |
基本平均股數(千股) | 27244.00 | 26879.00 | 26450.00 | 27973.00 | 19697.00 | 18316.00 | 17151.00 | - | 112479.00 | 110659.00 |
稀釋平均股數(千股) | 33100.00 | 29824.00 | 26450.00 | 27973.00 | 19697.00 | 18316.00 | 17151.00 | - | 112479.00 | 110659.00 |
還原基本每股稅後盈餘(元) | 0.13 | 0.50 | -0.48 | -0.16 | -0.76 | -0.73 | -1.04 | - | -0.94 | -3.65 |
還原稀釋每股稅後盈餘(元) | 0.12 | 0.50 | -0.48 | -0.26 | -0.67 | -0.72 | -1.04 | -0.53 | -0.80 | -3.67 |
還原基本平均股數(千股) | 27,244 | 26,879 | 26,450 | 27,973 | 19,697 | 18,316 | 17,151 | - | 7,498 | 7,377 |
還原稀釋平均股數(千股) | 33,100 | 29,824 | 26,450 | 27,973 | 19,697 | 18,316 | 17,151 | - | 7,498 | 7,377 |
EBITDA(千元) | 10,263 | 19,612 | -6,293 | -2,410 | -5,336 | -7,661 | -10,970 | -5,070 | -355 | -15,104 |